CONTEMPORARY THERAPEUTIC STRATEGIES IN LARYNGEAL CANCER: FROM ORGAN PRESERVATION TO PRECISION ONCOLOGY

Authors

Keywords:

laryngeal cancer, organ preservation, immunotherapy, targeted therapy, transoral surgery, radiotherapy, personalized medicine, molecular diagnostics, rehabilitation, precision oncology.

Abstract

Laryngeal cancer remains a clinically significant malignancy because effective treatment must achieve adequate oncological control while preserving vital functions such as respiration, swallowing, airway protection, and phonation. Conventional approaches, including surgery, radiotherapy, chemotherapy, and combined-modality treatment, remain fundamental; however, their potential impact on speech, swallowing, respiratory function, and long-term quality of life has stimulated the development of more selective and function-preserving strategies. Objective. The aim of this review was to summarize contemporary therapeutic approaches to laryngeal cancer, with particular emphasis on organ preservation, minimally invasive surgery, advanced radiotherapy, immunotherapy, targeted treatment, molecular diagnostics, personalized treatment planning, multidisciplinary care, and rehabilitation. Materials and Methods. A narrative analytical review was conducted using the scientific and clinical sources included in the original manuscript, including contemporary head and neck cancer guidelines, established evidence on organ-preservation chemoradiotherapy, oncological reference literature, and tumor-classification resources. Therapeutic approaches were assessed according to their role in local tumor control, preservation of laryngeal anatomy and function, treatment-related toxicity, patient selection, and integration into individualized multidisciplinary care. Results. Modern management of laryngeal cancer has evolved from a predominantly anatomy-based model toward a more individualized therapeutic strategy. Early-stage disease may be treated with organ-preserving surgery or radiotherapy, whereas locally advanced tumors frequently require multimodal treatment. Transoral laser microsurgery and other minimally invasive approaches may reduce surgical morbidity in appropriately selected patients. Modern radiation techniques allow increasingly precise dose delivery and improved protection of surrounding normal tissues. Immune checkpoint inhibition has expanded systemic treatment options in recurrent or metastatic head and neck squamous cell carcinoma, while targeted therapy and molecular profiling provide additional opportunities for biologically oriented treatment selection. Contemporary organ-preservation strategies increasingly emphasize functional rather than purely anatomical preservation. Conclusion. Effective management of laryngeal cancer requires a balance between tumor control and preservation of speech, swallowing, respiratory function, and quality of life. Integration of surgery, radiotherapy, systemic treatment, immunotherapy, molecular diagnostics, rehabilitation, and patient-centered decision-making within a multidisciplinary framework may improve individualized care. Further clinical research is required to identify predictive biomarkers, optimize treatment sequencing, and determine which emerging approaches provide meaningful improvements in survival and functional outcomes.

References

1.National Comprehensive Cancer Network. Head and Neck Cancers. Version 2.2024.

2.Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiation therapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–2098.

3.Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and Neck Cancers: Comprehensive Management. Springer; 2010.

4.WHO Classification of Tumours Editorial Board. Head and Neck Tumours. Lyon: International Agency for Research on Cancer; 2017.

Published

2026-09-25